Status:
COMPLETED
Phase II Study of HMPL-004 in Patients With Ulcerative Colitis
Lead Sponsor:
Hutchison Medipharma Limited
Conditions:
Ulcerative Colitis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of HMPL-004 in patients with active mild to moderate ulcerative colitis (UC), compared with placebo.
Detailed Description
This is a double-blind, randomized, placebo-controlled Phase II study conducted in North America (U.S. and Canada) and Europe (Romania and Ukraine) in patients with mild to moderate ulcerative colitis...
Eligibility Criteria
Inclusion
- Have active confirmed mild to moderate ulcerative colitis
Exclusion
- Diagnosed with Crohn's Disease or
Key Trial Info
Start Date :
February 7 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 13 2009
Estimated Enrollment :
224 Patients enrolled
Trial Details
Trial ID
NCT00659802
Start Date
February 7 2008
End Date
October 13 2009
Last Update
July 22 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.